Logo image of RYAM

RAYONIER ADVANCED MATERIALS (RYAM) Stock Fundamental Analysis

NYSE:RYAM - New York Stock Exchange, Inc. - US75508B1044 - Common Stock - Currency: USD

7.38  +0.3 (+4.24%)

After market: 7.38 0 (0%)

Fundamental Rating

2

RYAM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. RYAM has a bad profitability rating. Also its financial health evaluation is rather negative. RYAM has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

RYAM had negative earnings in the past year.
In the past year RYAM had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: RYAM reported negative net income in multiple years.
Each year in the past 5 years RYAM had a positive operating cash flow.
RYAM Yearly Net Income VS EBIT VS OCF VS FCFRYAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of -3.91%, RYAM is doing worse than 77.11% of the companies in the same industry.
RYAM's Return On Equity of -11.51% is on the low side compared to the rest of the industry. RYAM is outperformed by 77.11% of its industry peers.
RYAM's Return On Invested Capital of 3.42% is in line compared to the rest of the industry. RYAM outperforms 42.17% of its industry peers.
Industry RankSector Rank
ROA -3.91%
ROE -11.51%
ROIC 3.42%
ROA(3y)-0.86%
ROA(5y)-0.76%
ROE(3y)-2.43%
ROE(5y)-2.35%
ROIC(3y)N/A
ROIC(5y)N/A
RYAM Yearly ROA, ROE, ROICRYAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300

1.3 Margins

RYAM has a worse Operating Margin (4.77%) than 65.06% of its industry peers.
In the last couple of years the Operating Margin of RYAM has declined.
RYAM's Gross Margin of 9.57% is on the low side compared to the rest of the industry. RYAM is outperformed by 86.75% of its industry peers.
In the last couple of years the Gross Margin of RYAM has declined.
Industry RankSector Rank
OM 4.77%
PM (TTM) N/A
GM 9.57%
OM growth 3YN/A
OM growth 5Y-42.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.37%
GM growth 5Y-16.92%
RYAM Yearly Profit, Operating, Gross MarginsRYAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RYAM is destroying value.
RYAM has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, RYAM has more shares outstanding
Compared to 1 year ago, RYAM has an improved debt to assets ratio.
RYAM Yearly Shares OutstandingRYAM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
RYAM Yearly Total Debt VS Total AssetsRYAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

RYAM has an Altman-Z score of 1.44. This is a bad value and indicates that RYAM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.44, RYAM is doing worse than 66.27% of the companies in the same industry.
RYAM has a debt to FCF ratio of 8.52. This is a slightly negative value and a sign of low solvency as RYAM would need 8.52 years to pay back of all of its debts.
RYAM has a Debt to FCF ratio of 8.52. This is comparable to the rest of the industry: RYAM outperforms 55.42% of its industry peers.
RYAM has a Debt/Equity ratio of 1.02. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.02, RYAM is not doing good in the industry: 69.88% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 8.52
Altman-Z 1.44
ROIC/WACC0.39
WACC8.71%
RYAM Yearly LT Debt VS Equity VS FCFRYAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

RYAM has a Current Ratio of 1.73. This is a normal value and indicates that RYAM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.73, RYAM is doing worse than 63.86% of the companies in the same industry.
A Quick Ratio of 1.09 indicates that RYAM should not have too much problems paying its short term obligations.
RYAM has a worse Quick ratio (1.09) than 61.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.09
RYAM Yearly Current Assets VS Current LiabilitesRYAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

3

3. Growth

3.1 Past

RYAM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -215.52%.
The Revenue has decreased by -5.27% in the past year.
RYAM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.43% yearly.
EPS 1Y (TTM)-215.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.23%
Revenue 1Y (TTM)-5.27%
Revenue growth 3Y6.94%
Revenue growth 5Y-3.43%
Sales Q2Q%8.77%

3.2 Future

RYAM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.04% yearly.
Based on estimates for the next years, RYAM will show a small growth in Revenue. The Revenue will grow by 2.84% on average per year.
EPS Next Y93.5%
EPS Next 2Y44.48%
EPS Next 3Y31.04%
EPS Next 5YN/A
Revenue Next Year-0.42%
Revenue Next 2Y1.88%
Revenue Next 3Y2.84%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
RYAM Yearly Revenue VS EstimatesRYAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
RYAM Yearly EPS VS EstimatesRYAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1 2 -2

4

4. Valuation

4.1 Price/Earnings Ratio

RYAM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 33.65, which means the current valuation is very expensive for RYAM.
Based on the Price/Forward Earnings ratio, RYAM is valued a bit more expensive than 66.27% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. RYAM is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 33.65
RYAM Price Earnings VS Forward Price EarningsRYAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RYAM is valued cheaply inside the industry as 93.98% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, RYAM is valued cheaply inside the industry as 96.39% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.36
EV/EBITDA 5.12
RYAM Per share dataRYAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

RYAM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as RYAM's earnings are expected to grow with 31.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.48%
EPS Next 3Y31.04%

0

5. Dividend

5.1 Amount

No dividends for RYAM!.
Industry RankSector Rank
Dividend Yield N/A

RAYONIER ADVANCED MATERIALS

NYSE:RYAM (2/21/2025, 8:04:00 PM)

After market: 7.38 0 (0%)

7.38

+0.3 (+4.24%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-05 2024-11-05/amc
Earnings (Next)03-05 2025-03-05/amc
Inst Owners80.56%
Inst Owner Change1.47%
Ins Owners3.49%
Ins Owner Change1.49%
Market Cap486.49M
Analysts82.86
Price Target12.75 (72.76%)
Short Float %1.53%
Short Ratio2.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)119.62%
Min EPS beat(2)-53.45%
Max EPS beat(2)292.69%
EPS beat(4)2
Avg EPS beat(4)-523.3%
Min EPS beat(4)-2413.48%
Max EPS beat(4)292.69%
EPS beat(8)3
Avg EPS beat(8)-284.7%
EPS beat(12)5
Avg EPS beat(12)-189.87%
EPS beat(16)6
Avg EPS beat(16)-229.06%
Revenue beat(2)1
Avg Revenue beat(2)-1.36%
Min Revenue beat(2)-4.14%
Max Revenue beat(2)1.41%
Revenue beat(4)2
Avg Revenue beat(4)-3.34%
Min Revenue beat(4)-11.47%
Max Revenue beat(4)1.41%
Revenue beat(8)4
Avg Revenue beat(8)-2.07%
Revenue beat(12)6
Avg Revenue beat(12)-1.33%
Revenue beat(16)6
Avg Revenue beat(16)-7.17%
PT rev (1m)0%
PT rev (3m)31.58%
EPS NQ rev (1m)-7.7%
EPS NQ rev (3m)37.08%
EPS NY rev (1m)-18.52%
EPS NY rev (3m)26.16%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)2.62%
Revenue NY rev (1m)-0.12%
Revenue NY rev (3m)0.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 33.65
P/S 0.3
P/FCF 5.36
P/OCF 2.4
P/B 0.66
P/tB 0.68
EV/EBITDA 5.12
EPS(TTM)-1.83
EYN/A
EPS(NY)0.22
Fwd EY2.97%
FCF(TTM)1.38
FCFY18.65%
OCF(TTM)3.08
OCFY41.7%
SpS24.73
BVpS11.12
TBVpS10.93
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.91%
ROE -11.51%
ROCE 4.33%
ROIC 3.42%
ROICexc 3.7%
ROICexgc 3.73%
OM 4.77%
PM (TTM) N/A
GM 9.57%
FCFM 5.57%
ROA(3y)-0.86%
ROA(5y)-0.76%
ROE(3y)-2.43%
ROE(5y)-2.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-42.11%
ROICexc growth 3YN/A
ROICexc growth 5Y-41.95%
OM growth 3YN/A
OM growth 5Y-42.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.37%
GM growth 5Y-16.92%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 1.02
Debt/FCF 8.52
Debt/EBITDA 3.47
Cap/Depr 81.33%
Cap/Sales 6.88%
Interest Coverage 1.08
Cash Conversion 94.09%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 1.09
Altman-Z 1.44
F-Score5
WACC8.71%
ROIC/WACC0.39
Cap/Depr(3y)87.57%
Cap/Depr(5y)76.15%
Cap/Sales(3y)7.53%
Cap/Sales(5y)7.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-215.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%69.23%
EPS Next Y93.5%
EPS Next 2Y44.48%
EPS Next 3Y31.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.27%
Revenue growth 3Y6.94%
Revenue growth 5Y-3.43%
Sales Q2Q%8.77%
Revenue Next Year-0.42%
Revenue Next 2Y1.88%
Revenue Next 3Y2.84%
Revenue Next 5YN/A
EBIT growth 1Y512.05%
EBIT growth 3YN/A
EBIT growth 5Y-44.67%
EBIT Next Year2469.45%
EBIT Next 3Y216.74%
EBIT Next 5YN/A
FCF growth 1Y179.1%
FCF growth 3Y-43.34%
FCF growth 5Y-40.78%
OCF growth 1Y501.97%
OCF growth 3Y3.06%
OCF growth 5Y-11.21%